Annual ROA
-37.87%
-3.66%-10.70%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual return on assets is -37.87%, with the most recent change of -3.66% (-10.70%) on December 31, 2023.
- During the last 3 years, TCRX annual ROA has risen by +14.66% (+27.91%).
- TCRX annual ROA is now -36.91% below its all-time high of -27.66%, reached on December 31, 2019.
Performance
TCRX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-36.44%
-1.55%-4.44%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly return on assets is -36.44%, with the most recent change of -1.55% (-4.44%) on September 30, 2024.
- Over the past year, TCRX quarterly ROA has increased by +2.08% (+5.40%).
- TCRX quarterly ROA is now -21.87% below its all-time high of -29.90%, reached on March 31, 2021.
Performance
TCRX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
TCRX ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.7% | +5.4% |
| 3 y3 years | +27.9% | +5.4% |
| 5 y5 years | -36.9% | +5.4% |
TCRX ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.7% | +7.4% | -7.0% | +13.8% |
| 5 y | 5-year | -36.9% | +27.9% | -21.9% | +30.6% |
| alltime | all time | -36.9% | +27.9% | -21.9% | +30.6% |
TScan Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -36.44%(+4.4%) |
| Jun 2024 | - | -34.89%(-6.7%) |
| Mar 2024 | - | -37.38%(+5.0%) |
| Dec 2023 | -37.87%(+10.7%) | -35.60%(-7.6%) |
| Sep 2023 | - | -38.52%(-4.9%) |
| Jun 2023 | - | -40.49%(-4.3%) |
| Mar 2023 | - | -42.29%(+11.5%) |
| Dec 2022 | -34.21% | -37.92%(+8.1%) |
| Sep 2022 | - | -35.09%(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -36.33%(+6.3%) |
| Mar 2022 | - | -34.17%(+0.3%) |
| Dec 2021 | -40.89%(-22.2%) | -34.07%(+6.0%) |
| Sep 2021 | - | -32.14%(+2.4%) |
| Jun 2021 | - | -31.40%(+5.0%) |
| Mar 2021 | - | -29.90%(-43.1%) |
| Dec 2020 | -52.53%(+89.9%) | - |
| Dec 2020 | - | -52.53% |
| Dec 2019 | -27.66% | - |
FAQ
- What is TScan Therapeutics annual return on assets?
- What is the all time high annual ROA for TScan Therapeutics?
- What is TScan Therapeutics annual ROA year-on-year change?
- What is TScan Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for TScan Therapeutics?
- What is TScan Therapeutics quarterly ROA year-on-year change?
What is TScan Therapeutics annual return on assets?
The current annual ROA of TCRX is -37.87%
What is the all time high annual ROA for TScan Therapeutics?
TScan Therapeutics all-time high annual return on assets is -27.66%
What is TScan Therapeutics annual ROA year-on-year change?
Over the past year, TCRX annual return on assets has changed by -3.66% (-10.70%)
What is TScan Therapeutics quarterly return on assets?
The current quarterly ROA of TCRX is -36.44%
What is the all time high quarterly ROA for TScan Therapeutics?
TScan Therapeutics all-time high quarterly return on assets is -29.90%
What is TScan Therapeutics quarterly ROA year-on-year change?
Over the past year, TCRX quarterly return on assets has changed by +2.08% (+5.40%)